Cytochrome P450 Enzymes: |
---|
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 5.249E-09 | 3.810E-05 | CA1, CA12, CA13, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 1.115E-08 | 4.966E-05 | AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, HSD11B1, NPC1, NR1H4 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 1.497E-08 | 5.431E-05 | CA1, CA12, CA13, CA7, CA9 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 6.483E-07 | 8.823E-04 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0035335; peptidyl-tyrosine dephosphorylation | 9.178E-07 | 1.052E-03 | ACP1, CDC25B, PTPN1, PTPN2, PTPRF |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 7.088E-06 | 6.431E-03 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0008152; metabolic process | GO:0009404; toxin metabolic process | 9.415E-06 | 6.714E-03 | CYP1A1, CYP1A2, CYP1B1 |
BP | GO:0009987; cellular process | GO:0038183; bile acid signaling pathway | 9.558E-06 | 6.714E-03 | GPBAR1, NR1H4 |
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 4.297E-11 | 9.356E-07 | CA1, CA12, CA13, CA7, CA9 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 9.415E-06 | 6.714E-03 | CYP1A1, CYP1A2, CYP1B1 |
Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|
hsa00040 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.806E-03 | 1.799E-02 | AKR1B10; AKR1B1 |
hsa00051 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.428E-03 | 1.799E-02 | AKR1B10; AKR1B1 |
hsa00052 | Galactose metabolism_Homo sapiens_hsa00052 | 1.930E-05 | 4.117E-04 | AKR1B10; GAA; AKR1B1 |
hsa00140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 3.117E-06 | 1.995E-04 | HSD11B1; CYP1A2; CYP1A1; CYP1B1 |
hsa00380 | Tryptophan metabolism_Homo sapiens_hsa00380 | 4.640E-05 | 8.484E-04 | CYP1A2; CYP1A1; CYP1B1 |
hsa00561 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 4.782E-03 | 3.772E-02 | AKR1B10; AKR1B1 |
hsa00591 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.173E-03 | 1.668E-02 | PLA2G1B; CYP1A2 |
hsa00830 | Retinol metabolism_Homo sapiens_hsa00830 | 5.775E-03 | 4.107E-02 | CYP1A2; CYP1A1 |
hsa00910 | Nitrogen metabolism_Homo sapiens_hsa00910 | 7.425E-11 | 9.503E-09 | CA12; CA1; CA7; CA9; CA13 |
hsa00980 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 7.850E-06 | 2.652E-04 | HSD11B1; CYP1A2; CYP1A1; CYP1B1 |
ICD10 Disease Category | Disease Name | ICD10 Code | Linked Targets |
---|---|---|---|
A00-B99: Certain infectious and parasitic diseases | Fungal infections | B35-B49 | RAB9A |
A00-B99: Certain infectious and parasitic diseases | Pediculus humanus capitis | B85.0 | ACHE |
A00-B99: Certain infectious and parasitic diseases | Helminth infection | A00-B99 | ACHE |
A00-B99: Certain infectious and parasitic diseases | Infections | A00-B99 | PTPN1 |
A00-B99: Certain infectious and parasitic diseases | Visceral leishmaniasis | B55.0 | PLA2G1B |
A00-B99: Certain infectious and parasitic diseases | Leishmaniasis | B55.0 | PLA2G1B |
C00-D49: Neoplasms | Inflammatory disease | C11, C44, K75.9, M00-M25 | PLA2G1B |
C00-D49: Neoplasms | Clear cell renal cell carcinoma | C64 | CA9 |
C00-D49: Neoplasms | Renal cancer | C64 | CA9 |
C00-D49: Neoplasms | Lymphoma | C81-C86 | CA9 |